ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Aclarion Inc

Aclarion Inc (ACON)

0,2984
0,1564
(110,14%)
Fermé 06 Janvier 10:00PM
0,20
-0,0984
(-32,98%)
Après les heures de négociation: 1:59AM
Graphique avancé
Rendering Error

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,20
Prix Achat
0,10
Prix Vente
0,20
Volume échangé
305 639 827
0,1401 Fourchette du Jour 0,3869
0,10 Plage de 52 semaines 6,75
Cap du marché
Clôture Veille
0,142
Ouverture
0,148
Dernière Transaction
20000
@
0.2
(formt)
Dernière heure de transaction
Volume financier
US$ 76 017 546
VWAP
0,248716
Volume moyen (3 m)
798 549
Actions en circulation
10 431 159
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,64
Bénéfice par action (BPA)
-0,47
Chiffre d'affairess
75k
Bénéfice net
-4,91M

À propos de Aclarion Inc

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments.

Secteur
Medical Laboratories
Industrie
Medical Laboratories
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Aclarion Inc est coté dans le secteur Medical Laboratories de la NASDAQ avec le ticker ACON. Le dernier cours de clôture d'Aclarion était de US$0,14. Au cours de la dernière année, les actions de Aclarion ont été négociées dans une fourchette de prix de US$ 0,10 à US$ 6,75.

Aclarion compte actuellement 10 431 159 actions en circulation. La capitalisation boursière d'Aclarion est de US$1,48 million. Aclarion a un ratio cours/bénéfice (ratio PE) de -0.64.

ACON Dernières nouvelles

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Article Focuses on how Leading Physicians are Incorporating Nociscan Into Their Clinical Practices for Chronic Low Back Pain Patients MAGNETOM Flash is a Peer-to-Peer Magazine Published by...

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024 BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Modic Changes (MC) are MRI Findings Associated With Endplate Damage, Neoinnervation, and Chronic Low Back Pain (cLBP) MR Spectroscopy (MRS) Measurement of Intradiscal Propionic Acid (PA) can...

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive Q&A with Brent Ness, CEO and Director of Aclarion, Inc. (Nasdaq: ACON). As a disruptive healthcare...

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing...

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response LIFEHAB is a Randomized Controlled...

Aclarion Added to PRISM Emerging Medical Devices Index

Company's industry-first technology addresses chronic low back painAclarion secured its first commercial agreement with Michigan's Sheridan Community HospitalPRISM Emerging Medical Devices Index...

Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market

Justin Kubeck, M.D. of Ocean Pain and Spine in Toms River, NJ Will Lead a Statewide Network of Providers That Use Nociscan to Better Serve This Important Segment of Low Back Pain Population...

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

CLUE is a Multi-center Trial to Identify how Often Nociscan’s AI Data Changes the Initial Treatment Plan for Patients With Chronic Low Back Pain Dr. Justin Kubeck Will Initiate CLUE in New Jersey...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.049532.89036544850.15050.29840.128611855530.14316268CS
40.0317.64705882350.170.29840.115349210.14042699CS
120.018410.13215859030.18160.29840.17985490.1632144CS
26-0.0909-31.24785149540.29090.34590.16111990.19012005CS
52-3.0544-93.8544739433.25446.750.114199540.96423447CS
156-46.2-99.568965517246.464.80.110304699.70598886CS
260-46.2-99.568965517246.464.80.110304699.70598886CS

ACON - Frequently Asked Questions (FAQ)

What is the current Aclarion share price?
The current share price of Aclarion is US$ 0,20
How many Aclarion shares are in issue?
Aclarion has 10 431 159 shares in issue
What is the market cap of Aclarion?
The market capitalisation of Aclarion is USD 1,48M
What is the 1 year trading range for Aclarion share price?
Aclarion has traded in the range of US$ 0,10 to US$ 6,75 during the past year
What is the PE ratio of Aclarion?
The price to earnings ratio of Aclarion is -0,64
What is the cash to sales ratio of Aclarion?
The cash to sales ratio of Aclarion is 41,67
What is the reporting currency for Aclarion?
Aclarion reports financial results in USD
What is the latest annual turnover for Aclarion?
The latest annual turnover of Aclarion is USD 75k
What is the latest annual profit for Aclarion?
The latest annual profit of Aclarion is USD -4,91M
What is the registered address of Aclarion?
The registered address for Aclarion is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Aclarion website address?
The website address for Aclarion is www.aclarion.com
Which industry sector does Aclarion operate in?
Aclarion operates in the MEDICAL LABORATORIES sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,8M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
161,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
1,04M
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,59M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,5M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230,01M

ACON Bilan

Bilan
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock